Osaki Y - Search Results

1

Peretinoin after curative therapy of hepatitis C-related hepatocellular carcinoma: a randomized double-blind placebo-controlled study.

Okita K, Izumi N, Matsui O, Tanaka K, Kaneko S, Moriwaki H, Ikeda K, Osaki Y, Numata K, Nakachi K, Kokudo N, Imanaka K, Nishiguchi S, Okusaka T, Nishigaki Y, Shiomi S, Kudo M, Ido K, Karino Y, Hayashi N, Ohashi Y, Makuuchi M, Kumada H; Peretinoin Study Group. Okita K, et al. Among authors: osaki y. J Gastroenterol. 2015 Feb;50(2):191-202. doi: 10.1007/s00535-014-0956-9. Epub 2014 Apr 13. J Gastroenterol. 2015. PMID: 24728665 Free PMC article. Clinical Trial.

2

Randomized, double-blind, placebo-controlled trial of bovine lactoferrin in patients with chronic hepatitis C.

Ueno H, Sato T, Yamamoto S, Tanaka K, Ohkawa S, Takagi H, Yokosuka O, Furuse J, Saito H, Sawaki A, Kasugai H, Osaki Y, Fujiyama S, Sato K, Wakabayashi K, Okusaka T. Ueno H, et al. Among authors: osaki y. Cancer Sci. 2006 Oct;97(10):1105-10. doi: 10.1111/j.1349-7006.2006.00274.x. Cancer Sci. 2006. PMID: 16984383 Free PMC article. Clinical Trial.

3

Diagnostic accuracy of imaging for liver cirrhosis compared to histologically proven liver cirrhosis. A multicenter collaborative study.

Kudo M, Zheng RQ, Kim SR, Okabe Y, Osaki Y, Iijima H, Itani T, Kasugai H, Kanematsu M, Ito K, Usuki N, Shimamatsu K, Kage M, Kojiro M. Kudo M, et al. Among authors: osaki y. Intervirology. 2008;51 Suppl 1:17-26. doi: 10.1159/000122595. Epub 2008 Jun 10. Intervirology. 2008. PMID: 18544944

4

A new prognostic staging system for hepatocellular carcinoma: value of the biomarker combined Japan integrated staging score.

Kitai S, Kudo M, Minami Y, Ueshima K, Chung H, Hagiwara S, Inoue T, Ishikawa E, Takahashi S, Asakuma Y, Haji S, Osaki Y, Oka H, Seki T, Kasugai H, Sasaki Y, Matsunaga T. Kitai S, et al. Among authors: osaki y. Intervirology. 2008;51 Suppl 1:86-94. doi: 10.1159/000122599. Epub 2008 Jun 10. Intervirology. 2008. PMID: 18544953

5

Prognostic value of pretreatment levels of tumor markers for hepatocellular carcinoma on survival after curative treatment of patients with HCC.

Toyoda H, Kumada T, Kaneoka Y, Osaki Y, Kimura T, Arimoto A, Oka H, Yamazaki O, Manabe T, Urano F, Chung H, Kudo M, Matsunaga T. Toyoda H, et al. Among authors: osaki y. J Hepatol. 2008 Aug;49(2):223-32. doi: 10.1016/j.jhep.2008.04.013. Epub 2008 May 23. J Hepatol. 2008. PMID: 18571271

6

Validation of a new prognostic staging system for hepatocellular carcinoma: a comparison of the biomarker-combined Japan Integrated Staging Score, the conventional Japan Integrated Staging Score and the BALAD Score.

Kitai S, Kudo M, Minami Y, Haji S, Osaki Y, Oka H, Seki T, Kasugai H, Sasaki Y, Matsunaga T. Kitai S, et al. Among authors: osaki y. Oncology. 2008;75 Suppl 1:83-90. doi: 10.1159/000173428. Epub 2008 Dec 17. Oncology. 2008. PMID: 19092276

7

Transarterial chemotherapy alone versus transarterial chemoembolization for hepatocellular carcinoma: a randomized phase III trial.

Okusaka T, Kasugai H, Shioyama Y, Tanaka K, Kudo M, Saisho H, Osaki Y, Sata M, Fujiyama S, Kumada T, Sato K, Yamamoto S, Hinotsu S, Sato T. Okusaka T, et al. Among authors: osaki y. J Hepatol. 2009 Dec;51(6):1030-6. doi: 10.1016/j.jhep.2009.09.004. Epub 2009 Oct 1. J Hepatol. 2009. PMID: 19864035 Clinical Trial.

8

A novel biomarker TERTmRNA is applicable for early detection of hepatoma.

Miura N, Osaki Y, Nagashima M, Kohno M, Yorozu K, Shomori K, Kanbe T, Oyama K, Kishimoto Y, Maruyama S, Noma E, Horie Y, Kudo M, Sakaguchi S, Hirooka Y, Ito H, Kawasaki H, Hasegawa J, Shiota G. Miura N, et al. Among authors: osaki y. BMC Gastroenterol. 2010 May 18;10:46. doi: 10.1186/1471-230X-10-46. BMC Gastroenterol. 2010. PMID: 20482774 Free PMC article.

9

Effect of vitamin K2 on the recurrence of hepatocellular carcinoma.

Yoshida H, Shiratori Y, Kudo M, Shiina S, Mizuta T, Kojiro M, Yamamoto K, Koike Y, Saito K, Koyanagi N, Kawabe T, Kawazoe S, Kobashi H, Kasugai H, Osaki Y, Araki Y, Izumi N, Oka H, Tsuji K, Toyota J, Seki T, Osawa T, Masaki N, Ichinose M, Seike M, Ishikawa A, Ueno Y, Tagawa K, Kuromatsu R, Sakisaka S, Ikeda H, Kuroda H, Kokuryu H, Yamashita T, Sakaida I, Katamoto T, Kikuchi K, Nomoto M, Omata M. Yoshida H, et al. Among authors: osaki y. Hepatology. 2011 Aug;54(2):532-40. doi: 10.1002/hep.24430. Epub 2011 Jun 26. Hepatology. 2011. PMID: 21574174 Clinical Trial.

10

Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.

Kudo M, Izumi N, Kokudo N, Matsui O, Sakamoto M, Nakashima O, Kojiro M, Makuuchi M; HCC Expert Panel of Japan Society of Hepatology. Kudo M, et al. Dig Dis. 2011;29(3):339-64. doi: 10.1159/000327577. Epub 2011 Aug 9. Dig Dis. 2011. PMID: 21829027

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

655 results

Search Page

Filters